The present experiment evaluated the effects of naltrexone, a non-selective opioid receptor antagonist, on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J male mice. Home cage 2-bottle (alcohol vs. water) free-choice procedures were employed. During the pre-abstinence period, alcohol intake was much lower for the DBA/2J mice relative to the C57BL/6NCRL mice, and this strain difference was observed for groups receiving either 3% or 10% alcohol concentrations. The four-day abstinence period effectively reduced alcohol intakes (i.e., a negative alcohol deprivation effect, negative ADE) in both groups of DBA/2J mice, but had no effect on alcohol intakes in either group of C57BL/6NCRL mice. Both groups trained with 3% alcohol received the second four-day abstinence period, where the effects of acute administration of either naltrexone or saline on post-abstinence alcohol drinking were assessed. Naltrexone was more effective in reducing post-abstinence drinking of 3% alcohol in the DBA/2J mice than in the C57BL/6NCRL mice. In the DBA/2J mice, naltrexone further reduced, relative to saline-injected controls, the low levels of post-abstinence alcohol intake. Thus, the low baseline levels of alcohol drinking in DBA/2J mice were further diminished by the four-day abstinence period (negative ADE), and this suppressed post-abstinence level of alcohol drinking was still further reduced by acute administration of naltrexone. The results indicate that naltrexone is effective in reducing further the low levels of alcohol drinking induced by the negative ADE.
Introduction
Naltrexone, a non-selective opioid receptor antagonist, reduces alcohol drinking in rats and in mice (Coonfield et al., 2002; Davidson and Amit, 1997; Egli, 2005; Froehlich et al., 1990; Goodwin et al., 2001; Grahame et al., 2000; Heyser et al., 1997; Hubbell and Reid, 1988; Le et al., 1993; Middaugh et al., 1999a,b; Phillips et al., 1997; Salimov et al., 1995a,b; Volpicelli et al., 1986 ). Naltrexone's effects are particularly well-documented in high alcohol drinking strains of rats (Davidson and Amit, 1997; Dhaher et al., 2012; Heyser et al., 2003; Hill and Kiefer, 1997; Holter and Spanagel, 1999; Juarez and Eliana, 2007; Myers and Lankford, 1996) and in high alcohol drinking strains of mice, notably C57BL/6 and related sub-strains (Escher and Mittleman, 2006; Grahame et al., 2000; Kamdar et al., 2007; Kim et al., 2004; Phillips et al., 1997) . While it is clear that naltrexone reliably reduces high levels of alcohol drinking, its effects on lower levels of alcohol drinking have not been reported. For example, there are no published reports of naltrexone's effects on alcohol drinking in DBA/2J mice, an inbred mouse strain that exhibits little tendency to drink alcohol.
The present experiment investigated the effects of acute administration of naltrexone on alcohol drinking in two inbred strains of mice (C57BL/6NCRL and DBA/2J) known to differ in their tendencies to drink alcohol. Of primary interest are the effects of acute naltrexone administration on alcohol drinking following a period of alcohol abstinence. Relapse-like elevation of post-abstinence alcohol drinking (i.e., positive alcohol deprivation effect, or positive ADE) has been reported in rats and in mice (Holstein et al., 2011; Khisti et al., 2006; McKinzie et al., 1998; Melendez et al., 2006; Rodd et al., 2004; Rodd-Henricks et al., 2000a,b; Salimov and Salimova, 1993a,b; Salimov et al., 1993; Sinclair, 1972 Sinclair, , 1979 Sinclair and Li, 1989; Sinclair and Senter, 1967; Sparta et al., 2009; Tambour et al., 2008; Wolstenholme et al., 2011) . Although far less extensively studied, several reports indicate that in rodents, when alcohol drinking levels are low, the alcohol abstinence period may induce even less post-abstinence alcohol drinking than preabstinence baseline levels i.e., negative alcohol deprivation effect, or negative ADE (DiBattista, 1991; Melendez et al., 2006; Salimov et al., 1995a; Sinclair and Bender, 1978; Sinclair and Sheaff, 1973; Sinclair and Tiihonen, 1988 
